Post

FDA grants IND clearance for Drug Farm’s ROSAH syndrome trial

The US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of Drug Farm enabling the …

Vicore to kickstart Phase IIb IPF trial for buloxibutid

Vicore Pharma is looking to move ahead with the Phase IIb trial of its lead pipeline candidate buloxibutid after a …

Evrima pilots new patient recruitment approach for trials

Evrima Technologies has executed a pilot project with StrongRoomAI and Paratus Clinical, to offer new avenues for patients to discover …

Flexibility of alternative trial designs crucial for cell and gene therapy research

The traditional randomised controlled trial (RCT) model has been used for decades in drug development. Although it is considered the …

Oak Hill Bio and Chiesi enrol first subject in Phase IIb BPD trial in infants

Oak Hill Bio and Chiesi Group have announced the enrolment of the first subject in the resumed Phase IIb clinical …